1. Home
  2. BCRX

BCRX

BioCryst Pharmaceuticals Inc.

Logo BioCryst Pharmaceuticals Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 3:49pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Founded: 1986 Country:
United States
United States
Employees: 531 City: DURHAM
Market Cap: 983.3M IPO Year: 1994
Target Price: $13.29 AVG Volume (30 days): 3.1M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.18 EPS Growth: N/A
52 Week Low/High: $4.45 - $9.07 Next Earning Date: 05-01-2024
Revenue: $331,412,000 Revenue Growth: 22.37%
Revenue Growth (this year): 21.78% Revenue Growth (next year): 20.22%

Share on Social Networks: